| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 183,957 | 182,352 | 178,659 | 221,799 | | Cost of Revenue | 149,852 | 158,345 | 150,028 | 194,006 | | | Gross Profit | 34,105 | 24,007 | 28,631 | 27,793 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 20,254 | 2,625 | 15,982 | 15,864 | | Non Recurring |
-
| 58,395 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 13,851 | (37,013) | 12,649 | 11,929 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,652 | (17,489) | 7,944 | 2,211 | | Earnings Before Interest And Taxes | 16,503 | (54,502) | 20,593 | 14,140 | | Interest Expense | 13,244 | 8,401 | 8,344 | 9,296 | | Income Before Tax | 3,259 | (62,903) | 12,249 | 4,844 | | Income Tax Expense | 1,544 | (20,463) | 1,967 | 991 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,715 | (42,440) | 10,282 | 3,853 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,715 | (42,440) | 10,282 | 3,853 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,715 | ($42,440) | $10,282 | $3,853 |
|
0.02% Nasdaq 0.00%
Income Statement
